๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cost Effectiveness of Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Compared With Standard Concurrent Cisplatin and Radiation in Patients with Stage IIB to IVA Carcinoma of the Cervix

โœ Scribed by N. Phippen; C. Leath III; J. Chino; E. Jewell; L. Havrilesky; J. Barnett

Book ID
113964039
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
52 KB
Volume
125
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Efficacy in high burden locally advanced
Efficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chemoradiotherapy plus adjuvant gemcitabine and cisplatin: Prognostic and predictive factors and the impact of disease stage on outcomes from a prospective randomized phase III trial
โœ A. Dueลˆas-Gonzรกlez; M. Orlando; Y. Zhou; M. Quinlivan; H. Barraclough ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 603 KB
Prediction of treatment outcome by cispl
Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT)
โœ Frank J.P. Hoebers; Dick Pluim; Marcel Verheij; Alfons J.M. Balm; Harry Bartelin ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 188 KB ๐Ÿ‘ 1 views

## Abstract The purpose of our study was to test the predictive value of cisplatinโ€DNA adduct levels in head and neck squamous cell carcinoma (HNSCC) patients treated with cisplatinโ€radiation. Patients with advancedโ€stage HNSCC were treated within a randomized trial, investigating the optimal route